Compare · PRKS vs TMDX
PRKS vs TMDX
Side-by-side comparison of United Parks & Resorts Inc. (PRKS) and TransMedics Group Inc. (TMDX): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both PRKS and TMDX operate in Biotechnology: Electromedical & Electrotherapeutic Apparatus (Health Care), so they compete in similar markets.
- TMDX is the larger of the two at $2.65B, about 1.8x PRKS ($1.48B).
- PRKS has been more active in the news (13 items in the past 4 weeks vs 2 for TMDX).
- TMDX has more recent analyst coverage (20 ratings vs 8 for PRKS).
- Company
- United Parks & Resorts Inc.
- TransMedics Group Inc.
- Price
- -
- -
- Market cap
- $1.48B
- $2.65B
- 1M return
- -
- -18.36%
- 1Y return
- -
- -39.77%
- Industry
- Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Exchange
- NYSE
- NASDAQ
- IPO
- 2013
- 2019
- News (4w)
- 13
- 2
- Recent ratings
- 8
- 20
TransMedics Group Inc.
TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its Organ Care System includes OCS LUNG, a portable perfusion, ventilation, and monitoring system that maintains the organ at a near-physiologic state allowing physicians to assess and improve the condition of lungs between the donor and recipient sites; OCS Heart, a portable, warm perfusion, and monitoring system designed to keep a donor heart at a human-like, metabolically active state; and OCS Liver, a system that is evaluated in clinical trials for utilized and unutilized donor livers. TransMedics Group, Inc. was founded in 1998 and is headquartered in Andover, Massachusetts.
Latest PRKS
- UNITED PARKS & RESORTS INC. ANNOUNCES THIRD QUARTER 2026 EARNINGS RELEASE DATE AND CONFERENCE CALL INFORMATION
- Director Hartnett Timothy was granted 2,641 shares, increasing direct ownership by 3% to 84,019 units (SEC Form 4)
- Director Schaefer Kimberly was granted 602 shares, increasing direct ownership by 1% to 43,342 units (SEC Form 4)
- Director Narang Neha Jogani was granted 1,204 shares, increasing direct ownership by 2% to 58,580 units (SEC Form 4)
- Director Lipman Nathaniel was granted 301 shares, increasing direct ownership by 1% to 20,617 units (SEC Form 4)
- Director Gray William was granted 1,825 shares, increasing direct ownership by 2% to 78,546 units (SEC Form 4)
- Large owner Hill Path Capital Partners Co-Investment S Lp was granted 2,641 shares (SEC Form 4)
- Large owner Hill Path Capital Partners Lp was granted 2,641 shares (SEC Form 4)
- Director Chambers James P. was granted 1,592 shares, increasing direct ownership by 2% to 67,150 units (SEC Form 4)
- Chief Executive Officer Swanson Marc was granted 59,524 shares, increasing direct ownership by 15% to 447,454 units (SEC Form 4)
Latest TMDX
- Barclays initiated coverage on TransMedics Group with a new price target
- SEC Form 3 filed by new insider Araujo Fernando N.
- Director Weill David bought $109,058 worth of shares (1,336 units at $81.63), increasing direct ownership by 9% to 16,392 units (SEC Form 4)
- TransMedics Group Inc. filed SEC Form 8-K: Regulation FD Disclosure
- TransMedics Appoints Fernando Araujo as Chief Financial Officer and Reiterates 2026 Financial Outlook
- TransMedics to Present at Upcoming September Investor Conferences
- Director Tobin James R gifted 18,000 shares (SEC Form 4)
- SEC Form 10-Q filed by TransMedics Group Inc.
- TransMedics Group Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- TransMedics Reports Second Quarter 2026 Financial Results